Robert Ezzell
Corporate Officer/Principal bij ATAI LIFE SCIENCES N.V.
Profiel
Robert Ezzell is currently a Senior Director-Regulatory Affairs at ATAI Life Sciences NV since 2021.
Prior to this, he worked as a Director-Product Development at RenaMed Biologics, Inc., a Director-Regulatory Affairs at Glympse Bio, Inc., and an Assistant Professor at Harvard Medical School.
He holds a doctorate degree from the University of California, Berkeley.
Actieve functies van Robert Ezzell
| Bedrijven | Functie | Begin |
|---|---|---|
| ATAI LIFE SCIENCES N.V. | Corporate Officer/Principal | 01-01-2021 |
Eerdere bekende functies van Robert Ezzell
| Bedrijven | Functie | Einde |
|---|---|---|
RenaMed Biologics, Inc.
 RenaMed Biologics, Inc. Medical/Nursing ServicesHealth Services RenaMed Biologics, Inc. provided clinical cellular therapy. The company was founded by H. David Humes, James P. Sherblom and Richard A. Andrews in 1995 and was headquartered in Lincoln, RI. | Corporate Officer/Principal | - |
| Harvard Medical School | Corporate Officer/Principal | - |
Glympse Bio, Inc.
 Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | Algemeen Adviseur | - |
Opleiding van Robert Ezzell
| University of California, Berkeley | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ATAI LIFE SCIENCES N.V. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | Health Technology |
RenaMed Biologics, Inc.
RenaMed Biologics, Inc. Medical/Nursing ServicesHealth Services RenaMed Biologics, Inc. provided clinical cellular therapy. The company was founded by H. David Humes, James P. Sherblom and Richard A. Andrews in 1995 and was headquartered in Lincoln, RI. | Health Services |